Naltrexone Hydrochloride Accord Healthcare

Naltrexone Hydrochloride, the active ingredient in Naltrexone Hydrochloride Accord Healthcare, is an opioid antagonist presented as an oral tablet for oral use. It is employed in the management of alcohol dependence and in relapse‑prevention therapy for opioid‑dependent patients.

GNH USA supplies Naltrexone Hydrochloride Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naltrexone Hydrochloride acts on opioid‑related pathways to support recovery in dependence syndromes. - Alcohol dependence: reduces cravings and helps maintain abstinence. - Opioid dependence (relapse prevention): blocks opioid effects to deter relapse. - Opioid dependence (maintenance therapy): supports abstinence when combined with psychosocial support. - Alcohol dependence (treatment adjunct): may be used alongside counseling to improve outcomes.

Naltrexone Hydrochloride may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Fatigue: feeling of reduced energy.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe depression or suicidal ideation. - Allergic reactions: rash, itching, or swelling. - Liver failure: rare but life‑threatening. - Anaphylaxis: extremely rare systemic hypersensitivity.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events. - Liver function assessment: check baseline enzymes and monitor periodically. - Mental health screening: observe for depression or suicidal thoughts. - Avoid use during acute opioid withdrawal: may precipitate severe symptoms. - Renal impairment caution: adjust monitoring in patients with reduced kidney function. - Storage: Store at below 25°C: keep in the original pack, protect from moisture.

Naltrexone Hydrochloride can alter the activity of several concomitant medicines.

Major Interactions (Avoid): - Opioid analgesics: antagonizes analgesic effect, may precipitate withdrawal. - Disulfiram: combined hepatotoxic risk. - Benzodiazepines: increased risk of sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Antidepressants: potential for heightened depressive symptoms. - Antihypertensives: possible additive hypotensive effect. - Alcohol: may exacerbate liver stress and reduce treatment efficacy.